Your browser doesn't support javascript.
loading
Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer.
Lorusso, Domenica; Hilpert, Felix; González Martin, Antonio; Rau, Joern; Ottevanger, Petronella; Greimel, Elfriede; Lück, Hans-Joachim; Selle, Frédéric; Colombo, Nicoletta; Kroep, Judith R; Mirza, Mansoor R; Berger, Regina; Pardo, Beatriz; Grischke, Eva-Maria; Berton-Rigaud, Dominique; Martinez-Garcia, Jeronimo; Vergote, Ignace; Redondo, Andrés; Cardona, Andrés; Bastière-Truchot, Lydie; du Bois, Andreas; Kurzeder, Christian.
Afiliación
  • Lorusso D; Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy domenica.lorusso@policlinicogemelli.it.
  • Hilpert F; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) and Klinik für Gynäkologie und Geburtshilfe, Kiel, Germany (affiliation when work was performed).
  • González Martin A; Mammazentrum am Krankenhaus Jerusalem, Hamburg, Germany.
  • Rau J; Grupo Español de Investigación en Cáncer de Ovario (GEICO) and MD Anderson Cancer Center Spain, Madrid, Spain (affiliation when work was performed).
  • Ottevanger P; Clínica Universidad de Navarra, Madrid, Spain.
  • Greimel E; Coordinating Center for Clinical Trials, Philipps-University of Marburg, Marburg, Germany.
  • Lück HJ; Dutch Gynaecological Oncology Group (DGOG) and Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.
  • Selle F; Medical University Graz, Graz, Austria.
  • Colombo N; AGO and Gynäkologisch-Onkologische Praxis am Pelikanplatz, Hannover, Germany.
  • Kroep JR; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Groupe Hospitalier Diaconesses Croix Saint-Simon and Alliance Pour la Recherche en Cancérologie, Paris, France.
  • Mirza MR; Mario Negri Gynecologic Oncology (MaNGO) group, IEO, European Institute of Oncology IRCCS, and University of Milan-Bicocca, Milan, Italy.
  • Berger R; DGOG and Department of Medical Oncology, Leids Universitair Medisch Centrum, Leiden, Netherlands.
  • Pardo B; Nordic Society of Gynaecological Oncology (NSGO) and Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Grischke EM; AGO-Austria and University Hospital for Gynaecology and Obstetrics, Medical University of Innsbruck, Innsbruck, Austria.
  • Berton-Rigaud D; GEICO and Medical Oncology Department, Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona, Spain.
  • Martinez-Garcia J; AGO and University Hospital of Gynecology and Obstetrics, Tübingen, Germany.
  • Vergote I; GINECO and Integrated Center for Oncology Nantes-Angers, Nantes, France.
  • Redondo A; GEICO and Medical Oncology Service, Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Spain.
  • Cardona A; AGO and Leuven Cancer Institute, University Hospital Leuven, Leuven, Belgium.
  • Bastière-Truchot L; GEICO and Medical Oncology Department, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.
  • du Bois A; F. Hoffmann-La Roche, Basel, Switzerland.
  • Kurzeder C; F. Hoffmann-La Roche, Basel, Switzerland.
Int J Gynecol Cancer ; 29(7): 1141-1147, 2019 09.
Article en En | MEDLINE | ID: mdl-31420414
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / ARN Mensajero / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-3 / Anticuerpos Monoclonales Humanizados / Carcinoma Epitelial de Ovario Tipo de estudio: Clinical_trials Idioma: En Revista: Int J Gynecol Cancer Asunto de la revista: GINECOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / ARN Mensajero / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-3 / Anticuerpos Monoclonales Humanizados / Carcinoma Epitelial de Ovario Tipo de estudio: Clinical_trials Idioma: En Revista: Int J Gynecol Cancer Asunto de la revista: GINECOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article